Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Janone Inc JAN

JanOne Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying, acquiring, licensing, developing, partnering, and commercializing novel, no-opioid, and non-addictive therapies to address the large, unmet medical need for the treatment of pain and addiction. Its drug candidate, JAN101, is a patented oral, sustained-release pharmaceutical composition of sodium... see more

Recent & Breaking News (NDAQ:JAN)

JanOne Charts Ambitious Strategic Course for Non-Addictive Pain Management

PR Newswire January 26, 2023

JanOne Inc. Completes Acquisition of Soin Therapeutics, LLC

PR Newswire January 10, 2023

JanOne Inc. Executes Term Sheet to Acquire Soin Therapeutics LLC

PR Newswire September 16, 2022

ARCA Recycling, a Subsidiary of JanOne Inc., Unveils New Logo and Website

PR Newswire July 5, 2022

JanOne Inc. Announces an Improved Formulation of JAN101

PR Newswire June 28, 2022

ARCA Recycling, Inc., a Subsidiary of JanOne Inc., Opens Three New Recycling Centers in Washington, California and New Jersey

PR Newswire June 9, 2022

Emerging Markets Report: Right on Traq

GlobeNewswire June 8, 2022

JanOne Inc. Announces the Issuance of U.S. Patent Covering a Method of Improving Nerve Function Using JAN101

PR Newswire June 7, 2022

SPYR Technologies Enters into Material Definitive Agreement to Acquire GeoTraq, Inc.

GlobeNewswire May 31, 2022

JanOne Sells GeoTraq to SPYR Technologies in a $13.5 Million Transaction

PR Newswire May 31, 2022

JanOne Inc. Develops Plan for Treating Methamphetamine Use Disorder

PR Newswire January 4, 2022

ARCA Recycling, a Subsidiary of JanOne Inc., Awarded Recycling Contract in Virginia and North Carolina With Total Estimated Value of $1.6 Million for Work through 2023

PR Newswire December 16, 2021

JanOne Inc. Acquires an Option for the Rights to a Worldwide, Exclusive License for a Novel Strategy for Treating Methamphetamine Use Disorder

PR Newswire December 7, 2021

ARCA Recycling, a Subsidiary of JanOne Inc., Launches Two Recycling Programs in California in Effort to Reduce GHG Emissions

PR Newswire October 27, 2021

ARCA Recycling, a Subsidiary of JanOne Inc., Sees Major Increase in Appliance Replacement Contracts, Estimated to Push Revenue of Replacement Programs to Nearly $20 Million, in Addition to Recycling Business

PR Newswire October 19, 2021

ARCA Recycling, a Subsidiary of JanOne Inc., Opens Recycling Center in Michigan to Support New Multi-Year Contracts Totaling Millions in Revenue

PR Newswire October 12, 2021

ARCA Recycling, a Subsidiary of JanOne Inc., Awarded Recycling Contracts in Pennsylvania With Total Estimated Value of 20 Million Dollars for Work in the State to Continue Through 2026

PR Newswire October 7, 2021

ARCA Recycling, a Subsidiary of JanOne Inc., Opens New Pennsauken, NJ, Recycling Center, Launches New Recycling Programs

PR Newswire September 30, 2021

JanOne Encouraged By Recent FDA Communications Regarding Phase 2B Clinical Trial Design of Lead Drug Candidate JAN101

PR Newswire September 28, 2021

JanOne Selects CPC Clinical Research as Trial Manager for Phase 2b Study of JAN101 for Peripheral Artery Disease Patients

PR Newswire July 22, 2021